Since FGFR2 pathway interacts with major signalling pathways, including BMP, WNT, Notch and Hedgehog, its aberrant activity is associated with developmental defects resulting in metabolic disorders, and cancer including lymphoma (reviewed in [34]). This evidence concerns the gene FGFR2 and metabolic disease.